Supportive care for patients with gynaecological cancer

Authors

  • Jean Klastersky Centre des Tumeurs de l’Université Libre de Bruxelles
  • Dominique Lossignol Centre des Tumeurs de l’Université Libre de Bruxelles

Keywords:

gynaecological oncology, supportive therapy

Abstract

Close to 100000 new cases of invasive gynaecological malignancy are diagnosed each year, both in the United States and Western Europe, and account for about 30 000 deaths in either of these two geographical areas.1,2 Although many women will be cured eventually, most will require many months or years of treatment with major physical and psychological consequences, leading to substantial reduction in their quality of life (QOL).

Author Biographies

  • Jean Klastersky, Centre des Tumeurs de l’Université Libre de Bruxelles
    MD, PhD Professor and Chief of Medicine (emeritus)Institut Jules Bordet Centre des Tumeurs de l’Université Libre de Bruxelles
  • Dominique Lossignol, Centre des Tumeurs de l’Université Libre de Bruxelles
    MD Head Supportive Care Unit Institut Jules Bordet Centre des Tumeurs de l’Université Libre de Bruxelles

Downloads

Additional Files

Published

2011-05-26

Issue

Vol. 3 No. 2 (2011)

Section

Guest Editorial

License

South African Journal of Gynaecological Oncology (SAJGO) Copyright is held by South African Society of Gynaecologic Oncology (SASGO). Copyright of the articles is held by the authors. The work is licensed under a Creative Commons Attribution-Non-Commercial Works 4.0 South Africa License (CC BY NC). Material submitted for publication in the SAJGO is accepted provided it has not been published elsewhere. The SAJGO does not hold itself responsible for statements made by the authors. The opinions expressed in this publication are those of the authors. They do no purport to reflect the opinions or views of SASGO or its members.